ElevateBio

Powering the creation of cell & gene therapies at a speed the world deserves.

Elevated Insights

From gene editing to biomanufacturing, learn more about the cell and gene therapy industry from our team of industry-leading experts

Featured Insights

// Aug 2026

When Should You Engage a Cell and Gene Therapy CDMO? Earlier Than You Think.

By: Yogesh Waghmare, Senior Director, MSAT

View Insight

// Aug 2026

Partner Case Study: Accelerating CAR T-Cell Therapy Manufacturing for Autoimmune Disease

By: ElevateBio

View Insight

// Aug 2026

Targeted Gene Insertion Needs More Than One Tool

By: David Wiley, Director, Nucleic Acid Technology

View Insight

// Aug 2026

How Can AI-Directed Protein Engineering Improve Genomic Medicines?

By, Gavin Ellis, Senior Scientist, Translational Biology

View Insight

// Oct 2023

Biotechnology: The Key to America’s Next Manufacturing Revolution

By Heidi Wagner, Global Head of Government Affairs, and Mike Paglia, Chief Operating Officer of ElevateBio BaseCamp

View Insight

// Aug 2023

Partner Case Study: Accelerating Treg Therapy Manufacturing

By ElevateBio and Abata Therapeutics

View Insight

// Jan 2023

Reflecting on ElevateBio’s First Five Years

From our Chairman and CEO, David Hallal

View Insight

// Nov 2022

ElevateBio’s Lentiviral Vector Platform: Right the first time

By: Mercedes Segura, Vice President, Process Development, ElevateBio, Dawn Maier, Vice President, Emerging Technologies, ElevateBio, and Bojiao Yin, Director of Vector Process Development, ElevateBio

View Insight

// Nov 2022

The Medicines of Tomorrow: A primer on the gene editing landscape

By Adrian Oliver, Ph.D., Senior Scientist of Technology Development, Life Edit Therapeutics

View Insight

// Nov 2022

Right from the start: Successfully managing the life cycles of cell and gene therapies

By Mike Paglia, Chief Operating Officer ElevateBio BaseCamp

View Insight

MENU